CoChat

Metabolic Effects of the Intracellular Regulation of Thyroid Hormone: Old Players, New Concepts

Open access
Cicatiello, Annunziata G., Di Girolamo, Daniela, Dentice, Monica · 2018 · Frontiers in Endocrinology
Cited by 185

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

Thyroid hormones (THs) are key determinants of cellular metabolism and regulate a variety of pathways that are involved in the metabolism of carbohydrates, lipids and proteins in several target tissues. Notably, hyperthyroidism induces a hyper-metabolic state characterized by increased resting energy expenditure, reduced cholesterol levels, increased lipolysis and gluconeogenesis followed by weight loss, whereas hypothyroidism induces a hypo-metabolic state characterized by reduced energy expenditure, increased cholesterol levels, reduced lipolysis and gluconeogenesis followed by weight gain. Thyroid hormone is also a key regulator of mitochondria respiration and biogenesis. Besides mirroring systemic TH concentrations, the intracellular availability of TH is potently regulated in target cells by a mechanism of activation/inactivation catalyzed by three seleno-proteins: type 1 and type 2 iodothyronine deiodinase (D1 and D2) that convert the biologically inactive precursor thyroxine T4 into T3, and type 3 iodothyronine deiodinase (D3) that inactivates TH action. Thus, the pleiotropic effects of TH can fluctuate among tissues and strictly depend on the cell-autonomous action of the deiodinases. Here we review the mechanisms of TH action that mediate metabolic regulation. This review traces the critical impact of peripheral regulation of TH by the deiodinases on the pathways that regulate energy metabolism and the balance among energy intake, expenditure and storage in specific target tissues.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fendo.2018.00474

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 58

  1. Iwen, 2013, Thyroid hormones and the metabolic syndrome, Eur Thyroid J, 2, 83, 10.1159/000351249 · DOI · Paper page
  2. Lopez, 2013, Energy balance regulation by thyroid hormones at central level, Trends Mol Med, 19, 418, 10.1016/j.molmed.2013.04.004 · DOI · Paper page
  3. Oppenheimer, 1991, Functional relationship of thyroid hormone-induced lipogenesis, lipolysis, and thermogenesis in the rat, J Clin Invest, 87, 125, 10.1172/JCI114961 · DOI · Paper page
  4. Freake, 1989, The regulation of lipogenesis by thyroid hormone and its contribution to thermogenesis, Endocrinology, 125, 2868, 10.1210/endo-125-6-2868 · DOI · Paper page
  5. Haber, 1986, Stimulation of potassium efflux in rat liver by a low dose of thyroid hormone: evidence for enhanced cation permeability in the absence of Na,K-ATPase induction, Endocrinology, 118, 207, 10.1210/endo-118-1-207 · DOI
  6. Clausen, 1991, Significance of cation transport in control of energy metabolism and thermogenesis, Physiol Rev, 71, 733, 10.1152/physrev.1991.71.3.733 · DOI · Paper page
  7. Ortiga-Carvalho, 2016, Hypothalamus-pituitary-thyroid axis, Compr Physiol, 6, 1387, 10.1002/cphy.c150027 · DOI · Paper page
  8. Zhang, 2016, The Type 2 Deiodinase Thr92Ala polymorphism is associated with worse glycemic control in patients with type 2 diabetes mellitus: a systematic review and meta-analysis, J Diabetes Res, 2016, 5928726, 10.1155/2016/5928726 · DOI
  9. Canani, 2005, The type 2 deiodinase A/G (Thr92Ala) polymorphism is associated with decreased enzyme velocity and increased insulin resistance in patients with type 2 diabetes mellitus, J Clin Endocrinol Metab, 90, 3472, 10.1210/jc.2004-1977 · DOI · Paper page
  10. Nair, 2012, Association analyses of variants in the DIO2 gene with early-onset type 2 diabetes mellitus in Pima Indians, Thyroid, 22, 80, 10.1089/thy.2010.0455 · DOI · Paper page
  11. Bos, 2017, Thyroid signaling, insulin resistance, and 2 diabetes mellitus: a mendelian randomization study, J Clin Endocrinol Metab, 102, 1960, 10.1210/jc.2016-2816 · DOI
  12. Singh, 2016, Hepatic FOXO1 target genes are co-regulated by thyroid hormone via RICTOR protein deacetylation and MTORC2-AKT protein inhibition, J Biol Chem, 291, 198, 10.1074/jbc.M115.668673 · DOI
  13. Singh, 2013, FoxO1 deacetylation regulates thyroid hormone-induced transcription of key hepatic gluconeogenic genes, J Biol Chem, 288, 30365, 10.1074/jbc.M113.504845 · DOI
  14. Malik, 2002, The relationship between the thyroid gland and the liver, QJM, 95, 559, 10.1093/qjmed/95.9.559 · DOI · Paper page
  15. Christoffolete, 2010, Regulation of thyroid hormone activation via the liver X-receptor/retinoid X-receptor pathway, J Endocrinol, 205, 179, 10.1677/JOE-09-0448 · DOI
  16. Fonseca, 2015, Perinatal deiodinase 2 expression in hepatocytes defines epigenetic susceptibility to liver steatosis and obesity, Proc Natl Acad Sci USA., 112, 14018, 10.1073/pnas.1508943112 · DOI
  17. Fernandes, 2018, The foxo1-inducible transcriptional repressor Zfp125 causes hepatic steatosis and hypercholesterolemia, Cell Rep, 22, 523, 10.1016/j.celrep.2017.12.053 · DOI
  18. Aguayo-Mazzucato, 2013, Thyroid hormone promotes postnatal rat pancreatic beta-cell development and glucose-responsive insulin secretion through MAFA, Diabetes, 62, 1569, 10.2337/db12-0849 · DOI · Paper page
  19. Furuya, 2010, Liganded thyroid hormone receptor-alpha enhances proliferation of pancreatic beta-cells, J Biol Chem, 285, 24477, 10.1074/jbc.M109.100222 · DOI
  20. Lenzen, 1984, Thyroid hormones, gonadal and adrenocortical steroids and the function of the islets of Langerhans, Endocr Rev, 5, 411, 10.1210/edrv-5-3-411 · DOI · Paper page
  21. Chidakel, 2005, Peripheral metabolism of thyroid hormone and glucose homeostasis, Thyroid, 15, 899, 10.1089/thy.2005.15.899 · DOI · Paper page
  22. Lenzen, 1975, Thyroxine treatment and insulin secretion in the rat, Diabetologia, 11, 49, 10.1007/BF00422818 · DOI
  23. Ximenes, 2007, Triiodothyronine (T3)-mediated toxicity and induction of apoptosis in insulin-producing INS-1 cells, Life Sci, 80, 2045, 10.1016/j.lfs.2007.03.001 · DOI
  24. Klieverik, 2009, Thyroid hormone modulates glucose production via a sympathetic pathway from the hypothalamic paraventricular nucleus to the liver, Proc Natl Acad Sci USA., 106, 5966, 10.1073/pnas.0805355106 · DOI · Paper page
  25. Medina, 2011, The thyroid hormone-inactivating type III deiodinase is expressed in mouse and human beta-cells and its targeted inactivation impairs insulin secretion, Endocrinology, 152, 3717, 10.1210/en.2011-1210 · DOI · Paper page
  26. Taguchi, 2010, Impaired insulin secretion from the pancreatic islets of hypothyroidal growth-retarded mice, J Endocrinol, 206, 195, 10.1677/JOE-09-0465 · DOI
  27. Jorns, 2002, Thyroxine induces pancreatic beta cell apoptosis in rats, Diabetologia, 45, 851, 10.1007/s00125-002-0842-5 · DOI
  28. Cowley, 1999, Integration of NPY, AGRP, and melanocortin signals in the hypothalamic paraventricular nucleus: evidence of a cellular basis for the adipostat, Neuron, 24, 155, 10.1016/S0896-6273(00)80829-6 · DOI · Paper page
  29. Coppola, 2005, Suppression of hypothalamic deiodinase type II activity blunts TRH mRNA decline during fasting, FEBS Lett, 579, 4654, 10.1016/j.febslet.2005.07.035 · DOI · Paper page
  30. Hernandez, 2010, Type 3 deiodinase deficiency causes spatial and temporal alterations in brain T3 signaling that are dissociated from serum thyroid hormone levels, Endocrinology, 151, 5550, 10.1210/en.2010-0450 · DOI · Paper page
  31. Wu, 2017, Type 3 deiodinase role on central thyroid hormone action affects the leptin-melanocortin system and circadian activity, Endocrinology, 158, 419, 10.1210/en.2016-1680 · DOI
  32. Dunn, 2017, Diurnal and photoperiodic changes in thyrotrophin-stimulating hormone beta expression and associated regulation of deiodinase enzymes (DIO2, DIO3) in the female juvenile chicken hypothalamus, J Neuroendocrinol, 29, 10.1111/jne.12554 · DOI
  33. Nakao, 2008, Thyrotrophin in the pars tuberalis triggers photoperiodic response, Nature, 452, 317, 10.1038/nature06738 · DOI · Paper page
  34. Salvatore, 2014, Thyroid hormones and skeletal muscle–new insights and potential implications, Nat Rev Endocrinol, 10, 206, 10.1038/nrendo.2013.238 · DOI · Paper page
  35. Dentice, 2014, Intracellular inactivation of thyroid hormone is a survival mechanism for muscle stem cell proliferation and lineage progression, Cell Metab, 20, 1038, 10.1016/j.cmet.2014.10.009 · DOI · Paper page
  36. Dentice, 2013, The deiodinases and the control of intracellular thyroid hormone signaling during cellular differentiation, Biochim Biophys Acta, 1830, 3937, 10.1016/j.bbagen.2012.05.007 · DOI · Paper page
  37. Ambrosio, 2013, Epigenetic control of type 2 and 3 deiodinases in myogenesis: role of Lysine-specific Demethylase enzyme and FoxO3, Nucleic Acids Res, 41, 3551, 10.1093/nar/gkt065 · DOI · Paper page
  38. Dentice, 2010, The FoxO3/type 2 deiodinase pathway is required for normal mouse myogenesis and muscle regeneration, J Clin Invest, 120, 4021, 10.1172/JCI43670 · DOI · Paper page
  39. Simonides, 2008, Thyroid hormone as a determinant of metabolic and contractile phenotype of skeletal muscle, Thyroid, 18, 205, 10.1089/thy.2007.0256 · DOI · Paper page
  40. Bloise, 2018, Role of thyroid hormone in skeletal muscle physiology, J Endocrinol, 236, R57, 10.1530/JOE-16-0611 · DOI · Paper page
  41. Louzada, 2014, Type 2 iodothyronine deiodinase is upregulated in rat slow- and fast-twitch skeletal muscle during cold exposure, Am J Physiol Endocrinol Metab., 307, E1020, 10.1152/ajpendo.00637.2013 · DOI
  42. McAninch, 2014, Thyroid hormone signaling in energy homeostasis and energy metabolism, Ann N Y Acad Sci, 1311, 77, 10.1111/nyas.12374 · DOI · Paper page
  43. Ramadan, 2011, Type-2 iodothyronine 5'deiodinase (D2) in skeletal muscle of C57Bl/6 mice. II. Evidence for a role of D2 in the hypermetabolism of thyroid hormone receptor alpha-deficient mice, Endocrinology, 152, 3093, 10.1210/en.2011-0139 · DOI
  44. Bocco, 2016, Thyroid hormone activation by type 2 deiodinase mediates exercise-induced peroxisome proliferator-activated receptor-gamma coactivator-1alpha expression in skeletal muscle, J Physiol, 594, 5255, 10.1113/JP272440 · DOI · Paper page
  45. Obregon, 2014, Adipose tissues and thyroid hormones, Front Physiol, 5, 479, 10.3389/fphys.2014.00479 · DOI · Paper page
  46. Shu, 2017, A-FABP mediates adaptive thermogenesis by promoting intracellular activation of thyroid hormones in brown adipocytes, Nat Commun, 8, 14147, 10.1038/ncomms14147 · DOI · Paper page
  47. de Jesus, 2001, The type 2 iodothyronine deiodinase is essential for adaptive thermogenesis in brown adipose tissue, J Clin Invest, 108, 1379, 10.1172/JCI13803 · doi:10.1172/jci13803 · Paper page
  48. Castillo, 2011, Disruption of thyroid hormone activation in type 2 deiodinase knockout mice causes obesity with glucose intolerance and liver steatosis only at thermoneutrality, Diabetes, 60, 1082, 10.2337/db10-0758 · DOI · Paper page
  49. Fonseca, 2014, Tissue-specific inactivation of type 2 deiodinase reveals multilevel control of fatty acid oxidation by thyroid hormone in the mouse, Diabetes, 63, 1594, 10.2337/db13-1768 · DOI · Paper page
  50. Kinlaw, 1995, Direct evidence for a role of the “spot 14” protein in the regulation of lipid synthesis, J Biol Chem, 270, 16615, 10.1074/jbc.270.28.16615 · DOI · Paper page
  51. Bianco, 1998, Thyroxine 5′-deiodination mediates norepinephrine-induced lipogenesis in dispersed brown adipocytes, Endocrinology, 139, 571, 10.1210/endo.139.2.5737 · doi:10.1210/endo.139.2.5737 · Paper page
  52. Garcia, 2002, Growth factor regulation of uncoupling protein-1 mRNA expression in brown adipocytes, Am J Physiol Cell Physiol, 282, C105, 10.1152/ajpcell.01396.2000 · DOI
  53. Young, 1984, Brown adipose tissue in the parametrial fat pad of the mouse, FEBS Lett, 167, 10, 10.1016/0014-5793(84)80822-4 · DOI · Paper page
  54. Cousin, 1992, Occurrence of brown adipocytes in rat white adipose tissue: molecular and morphological characterization, J Cell Sci, 103, 931, 10.1242/jcs.103.4.931 · DOI · Paper page
  55. Calvo, 2011, Presence and regulation of D1 and D2 deiodinases in rat white adipose tissue, Metabolism, 60, 1207, 10.1016/j.metabol.2011.01.014 · DOI
  56. Harms, 2013, Brown and beige fat: development, function and therapeutic potential, Nat Med, 19, 1252, 10.1038/nm.3361 · DOI · Paper page
  57. Macek Jilkova, 2010, Modulation of type I iodothyronine 5′-deiodinase activity in white adipose tissue by nutrition: possible involvement of leptin, Physiol Res, 59, 561, 10.33549/physiolres.931866 · DOI
  58. Nomura, 2011, Type 2 iodothyronine deiodinase is expressed in human preadipocytes, Thyroid, 21, 305, 10.1089/thy.2010.0068 · DOI · Paper page

Cited by

See all 185

Metadata

Authors
Cicatiello, A. G., Di Girolamo, D., & Dentice, M.
Venue
Frontiers in Endocrinology
Published
2018-09-11
Volume
9
Pages
474-474
ISSN
1664-2392 (ISSN-L)
OpenAlex
W2906310843
Cited by
185
References
18
FWCI
8.36
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.